Epidural injection of hydromorphone for postoperative pain after episiotomy: a randomized controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Lu Y;Lu Y; Liu S; Liu S; Jing S; Jing S; Peng W; Peng W; Lin Y; Lin Y
  • Source:
    Scientific reports [Sci Rep] 2024 Oct 21; Vol. 14 (1), pp. 24704. Date of Electronic Publication: 2024 Oct 21.
  • Publication Type:
    Journal Article; Randomized Controlled Trial
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      Perineal incision resulting in post-partum pain and impact on puerperal life was the focus of our study. We recruited postpartum mothers who had undergone vaginal delivery to receive labor analgesia and episiotomy with an epidural injection of 0.5 mg hydromorphone to assess the therapeutic effects of postpartum analgesia. The participants were randomly allocated into two groups: the control group (Group NS) received an epidural injection of an equal amount of saline, while the study group (Group HY) received an epidural injection of 0.5 mg hydromorphone. We collected relevant data from electronic medical records to compare the differences between the two groups. The intervention group demonstrated lower pain scores at 4, 8, 12, 16, and 24 h compared to the control group (p < 0.001). Additionally, a higher number of patients in the control group required pain medication (7 (15.9%) compared to 2 (4.7%)). The time to first analgesia request in group NS was earlier than that in group HY (8.94 ± 1.27 h compared to 16.96 ± 3.38 h). The study group experienced higher rates of vomiting (P = 0.002) and itching (P < 0.001). However, there were no differences between the two groups in terms of urinary retention, dyskinesia, respiratory depression, dizziness, or neonatal feeding. The epidural injection of 0.5 mg hydromorphone proved to be effective in alleviating pain caused by maternal episiotomy and did not negatively affect neonatal feeding.Clinical trial registration: http://www.chictr.org.cn/usercenter.aspx identifier: ChiCTR2200064687.
      (© 2024. The Author(s).)
    • References:
      Curr Opin Anaesthesiol. 2023 Feb 1;36(1):109-116. (PMID: 36214542)
      Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):152-6. (PMID: 17681663)
      Int J Gen Med. 2023 Nov 16;16:5333-5341. (PMID: 38021064)
      J Clin Nurs. 2022 Mar;31(5-6):559-568. (PMID: 34121251)
      J Pers Med. 2023 Mar 17;13(3):. (PMID: 36983723)
      J Affect Disord. 2022 Sep 1;312:92-99. (PMID: 35716784)
      Eur J Pain. 2024 Feb;28(2):214-230. (PMID: 37650457)
      J Matern Fetal Neonatal Med. 2019 Oct;32(20):3470-3472. (PMID: 29656689)
      J Pain Res. 2022 Jun 04;15:1633-1645. (PMID: 35694199)
      Int Urogynecol J. 2020 Nov;31(11):2367-2375. (PMID: 32405659)
      J Gynecol Obstet Hum Reprod. 2020 May;49(5):101722. (PMID: 32112999)
      Complement Ther Med. 2020 Sep;53:102510. (PMID: 33066851)
      Rev Esp Anestesiol Reanim. 2015 Oct;62(8):436-42. (PMID: 25555717)
      Curr Opin Anaesthesiol. 2017 Dec;30(6):736-742. (PMID: 28938298)
      Anesth Analg. 2010 Jan 1;110(1):159-64. (PMID: 19910627)
      Drug Saf. 2023 Nov;46(11):1133-1148. (PMID: 37824028)
      Pain Rep. 2021 Jun 03;6(2):e933. (PMID: 34104839)
      Anesthesiology. 2005 Nov;103(5):1079-88; quiz 1109-10. (PMID: 16249683)
      Int J Obstet Anesth. 2017 May;30:16-22. (PMID: 28185794)
    • Grant Information:
      No. Z20210012 Health Commission of Guangxi Zhuang Autonomous Region Self-financed Scientific Research Project
    • Contributed Indexing:
      Keywords: Episiotomy; Hydromorphone; Labor analgesia; Neonatal feeding
    • Accession Number:
      Q812464R06 (Hydromorphone)
      0 (Analgesics, Opioid)
    • Publication Date:
      Date Created: 20241021 Date Completed: 20241021 Latest Revision: 20241024
    • Publication Date:
      20241024
    • Accession Number:
      PMC11494193
    • Accession Number:
      10.1038/s41598-024-75610-y
    • Accession Number:
      39433860